Diabetes with Proteinuria

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-04-22
Clinical Trial Update: Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. [Phase 4]
A decentralized N=1 trial evaluates individual response to dapagliflozin in type 2 diabetes patients, completed phase 4.